Celator Pharmaceuticals (CPXX)

[crudeoil24]

Doc, amazing volume; many catalyst at work driving up share price.

[LicharTin]

dropped for nothing and i had to sell half of my position SMH

[doc7]

i am in low few months ago sold some off at 11 sorry i did back in today at 16 plus


a lot on oncologists like thsi stock

[crudeoil24]

Added a few 13.65's > CPXX.

[crudeoil24]

Roth PT @ 24.00 > may raise again!

[crudeoil24]

MM's knocked out 100's of traders stop loss orders. CPXX will bounce back over next couple of sessions. Besides CEO's comments today are a positive catalyst.

[diandor]

Here we go again

[ShootinBlanks]

Market manipulation at its finest

[jaytea]

Yeah, WTF?
Halted again?

[diandor]

What just happened?

[bostonstrong]

Halted

[Tdash]

something happen

[ShootinBlanks]

Burn shorty!!!

[crudeoil24]

Pfizer or Merck or some other huge pharma.

[stockdawg44]

Buyout candidate CPXX $100+ per share imo, eventually!!!!

[crudeoil24]

Multiple 52-week highs today!!!!!

[Tdash]

so beast!!

[crudeoil24]

Possible 18 or 19+ today!

[stockdawg44]

CPXX BOOM!!!!!! lmao @ shorts on twits getting creamed!!!!

[ShootinBlanks]

Rapido!

[crudeoil24]

News: Celator(R) Pharmaceuticals Announces New Data for VYXEOS(TM) in FLT3-ITD Mutated AML Cells Derived from Patients with Newly Diagnosed AML to be Presented at the American Association for Cancer Research Annual Meeting
56 minutes ago - DJNF

EWING, N.J., April 18, 2016 /PRNewswire/ -- Celator Pharmaceuticals, Inc. (Nasdaq: CPXX) today announced that data for VYXEOS(TM) (cytarabine:daunorubicin) Liposome for Injection (also known as CPX-351), its lead product candidate, will be presented at the American Association for Cancer Research (AACR) Annual Meeting in New Orleans, LA, April 16-20, 2016.
The research was conducted in the laboratory of Dr. Jeffrey Tyner at Oregon Health & Science University. The objective of the research was to examine the ex vivo sensitivity of acute myeloid leukemia (AML) cells derived from newly diagnosed patients to VYXEOS. This work supports the observed clinical benefit of VYXEOS in high-risk AML patients and may provide a means of identifying patient genotypes/phenotypes most sensitive to VYXEOS.

"We continue to learn more about the unique activity of VYXEOS in AML and enhance our ability to match this performance with specific patient characteristics that could be predictive of improved outcomes," said Lawrence Mayer, Ph.D., President and Chief Scientific Officer at Celator. "The research being undertaken by Dr. Tyner reflects Celator's goal to elucidate the clinical benefits of VYXEOS by expanding our scientific understanding of its mechanism of action, particularly in AML cells with important molecular phenotypes."



Details on the AACR poster presentation:

CPX-351 cytotoxicity against fresh AML blasts is

increased for FLT3-ITD+ cells and correlates with drug

Presentation Title: uptake and clinical outcomes

Date/Time: Sunday, April 17, 2016 -- 1:00pm-5:00pm

Session Category: Poster Presentation

Session Title: ET01-03, Combination Chemotherapy

New Orleans Convention Center, Halls G-J Poster Section

Location: 15

Abstract Number: 287



The poster will be available on Celator's website (www.celatorpharma.com) at the conclusion of the AACR meeting.

[bigstocksnbonds]

Was anything announced in Louisiana today and what please? Thanks lots!!

[bigstocksnbonds]

Anything announced from Louisiana today yet please? Thanks!

[bigstocksnbonds]

Sunday in LA thank you cannot wait!! Thanks!!

[stockdawg44]

Sunday in Louisianna

[bigstocksnbonds]

Is there an event this weekend for CPXX please? Thanks!

[bigstocksnbonds]

Was there an event this weekend that happened here please?

[crudeoil24]

CPXX >> Next stop $16.00+

[Tdash]

Been moving so lovely

[stockdawg44]

CPXX 14.84 all time high!!!! Awesome!!!!

[stockdawg44]

CPXX $14.44, she's a rocking now!!!!!!
Cramer is an arse......

[reconranger]

http://www.streetinsider.com/Analyst+Comments/UPDATE%3A+Roth+Sees+Celator+Pharmas+%28CPXX%29+Vyxeos+Easily+Supplementing+Standard+of+Care+7%2B3+Therapy%3B+Affirms+at+Buy/11492949.html

[crudeoil24]

CPXX > Chief Executive Officer, will present an overview of the company at the 15th Annual Healthcare Conference in New York City, NY on Tuesday, April 12, 2016 at 11:20 a.m. Eastern Time.

Up 1200%+ YTD.

[crudeoil24]

CPXX is a great $$$$$ opportunity!

[stockdawg44]

BOOM CPXX, new all time high, busting a move here!!!!!

[stockdawg44]

slow and steady, chart and trend is looking perfect.

[crudeoil24]

Roth PT is now $22.00 as of March 16.

[crudeoil24]

I wonder if Roth has raised PT from $18.00 to much higher PT?

[europtiger]

Yes Ideed

[ShootinBlanks]

Big money has to be buying this up. Beautiful thing to watch and own

[europtiger]

Looks like go Time

[crudeoil24]

Interesting 8-K. Good ole boys club looking out for each other in regards to bonus and severance pay. Might as well throw in a box of Partagas Cigars. CPXX.

[ShootinBlanks]

Rapido!

[ShootinBlanks]

We've already had it. Should continue to run into the conference on the 16th in my opinion but we'll see. I bought some calls today just for the hell of it.

[sorkin]

Time for correction?

[$UPERMAN]

[ShootinBlanks]

Looking good once again this morning

[ShootinBlanks]

Only up 700% the last couple weeks....

[Lone Wolf]

Your kidding me right? We'll take subjectivity out here. Look where she opened in the week and where she closed out the week. Then you'll have your answer in how she held up.

[Tonyeight]

well said on chart still downtrend going on ????????
well see on coming monday fellas
may be buying app on dip